REFERENCES
- Dabernat H, Delmas C, Seguy M, Fourtillan JB, Girault J, Lareng MB. The activity of clarithromycin and its 14-hydroxy metabolite against H. influenzae, determined by in-vitro and serum bactericidal tests. J Antimicrob Chemother 1991; 27 (Supp A): 19-30.
- Berry V, Thorburn CE, Knott SJ, Woodnutt G. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneu-moniae and Haemophilus influenzae. Antimicrob Agents Chemother 1998; 42: 3193–3199.
- Conte JE, Golden JA, Duncan S, McKenna E, Zurlinden E. Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. Antimicrob Agents Chemother 1995; 39: 334–338.
- Fish DN, Gotfired MH, Danziger LH, Rodvold KA. Penetration of azithromycin in human serum and tissues. J Antimicrob Chemother 1998; 38: 876–878.
- Rodvold KA, Gotfried Mh, Danziger LH, Servi RJ. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob Agents Chemother 1997; 41: 1399–1402.
- Baldwin DR, Honeybourne D, Wise R. Pulmonary dis-position of antimicrobial agents: methodological considera-tions. Antimicrob Agents Chemother 1990; 36: 1171–1175.
- Gomez-Las R, Granizo JJ, Bouza E, Aguilar L, Garcia de Lomas J. Relationship between Streptococcus pneumoni-ae and Streptococcus pyogenes and resistance to macrolides in 11 Spanish hospitals. In: Abstracts of the 21” International Congress of Chemotherapy. Abstract P233. Birmingham, UK, 1999.
- Bauernfeind A, Jungwirth R, Eberlein E. Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens. Infection 1995; 23: 316–321.
- Bergman KL, Olsen KM, Peddicord TE, Fey PD, Rupp ME. Antimicrobial activities and postantibiotic effects of clar-ithromycin, 14-hydroxy-clarithromycin and azithromycin in epithelial cell lining fluid against clinical isolates of Haemophilus influenzae and Streptococcus pneumoniae. Antimicrob Agents Chemother 1999; 43: 1291–1293.
- Walker KJ, Larsson AJ, Zabinski RA, Rotschafer JC. Evaluation of antimicrobial activities of clarithromycin and 14-hydroxy-clarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model. Antimicrob Agents Chemother 1994; 38: 2003–2007.
- Balcabao IP, Aguilar L, Martin M, Dal-re R, Prieto J. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations. In vitro phar-macodynamic simulation. Antimicrob Agents Chemother 1996; 40: 2904–2906.
- Martín M, Aguilar L, Balcabao IP, Gomez-Las ML, Dal-Re R, Prieto J. In-vitro pharmacodynamic simulation of clavu-lanic acid concentrations on Staphylococcus aureus and Haemophilus influenzae I3-lactamase activity. J Antimicrob Chemother 1997; 39: 290–292.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically; Approved Standard Fifth Edition. NCCLS document M7-A5. National Committee for Clinical Laboratory Standards, 2000; Villanova, PA.
- Chu SY, Wilson DS. Clarithromycin pharmacokinetics in healthy young and elderly volunteers. J Clin Pharmacol 1992; 32: 1045–9.
- Martin SJ, Garvin CG. MIC and synergy testing of clar-ithromycin and 14-hydroxy clarithromycin, alone and in com-bination against penicillin-intermediate and resistant Streptococcus pneumoniae using checkerboard and time-kill assays. Abstracts of the 38th Interscience Conference on Antimicrobial Agents. San Diego, USA, 1998.